402 related articles for article (PubMed ID: 34557973)
1. Risk of major bleeding associated with concomitant use of anticancer drugs and direct oral anticoagulant in patients with cancer and atrial fibrillation.
Wang CL; Wu VC; Tu HT; Huang YT; Chen SW; Chu PH; Wen MS; Huang HL; Chang SH
J Thromb Thrombolysis; 2022 Apr; 53(3):633-645. PubMed ID: 34557973
[TBL] [Abstract][Full Text] [Related]
2. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
[TBL] [Abstract][Full Text] [Related]
3. Assessing major bleeding risk in atrial fibrillation patients concurrently taking non-vitamin K antagonist oral anticoagulants and antiepileptic drugs.
Wang CL; Wu VC; Chang KH; Tu HT; Kuo CF; Huang YT; Chu PH; Kuo CC; Chang SH
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):147-154. PubMed ID: 31384926
[TBL] [Abstract][Full Text] [Related]
4. Bleeding complications in patients with gastrointestinal cancer and atrial fibrillation treated with oral anticoagulants.
Ording AG; Søgaard M; Skjøth F; Grove EL; Lip GYH; Larsen TB; Nielsen PB
Cancer Med; 2021 Jul; 10(13):4405-4414. PubMed ID: 34114733
[TBL] [Abstract][Full Text] [Related]
5. Clinical profile of direct oral anticoagulants versus vitamin K anticoagulants in octogenarians with atrial fibrillation: a multicentre propensity score matched real-world cohort study.
Russo V; Attena E; Di Maio M; Mazzone C; Carbone A; Parisi V; Rago A; D'Onofrio A; Golino P; Nigro G
J Thromb Thrombolysis; 2020 Jan; 49(1):42-53. PubMed ID: 31385163
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation.
Douros A; Renoux C; Yin H; Filion KB; Suissa S; Azoulay L
Am J Med; 2019 Feb; 132(2):191-199.e12. PubMed ID: 30691551
[TBL] [Abstract][Full Text] [Related]
7. Safe co-administration of direct-acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study.
McDaniel K; Utz AE; Akbashev M; Fuller KG; Boyle A; Davidson K; Marra F; Shah S; Cartwright EJ; Arora AA; DuPont S; Miller LS
J Viral Hepat; 2022 Dec; 29(12):1073-1078. PubMed ID: 36103593
[TBL] [Abstract][Full Text] [Related]
8. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study.
Nakamura M; Yamashita T; Hayakawa A; Matsumoto T; Takita A; Hasegawa C; Uchino K; Sekine T; Iizuka T; Tanabe H; Kogure S
J Cardiol; 2021 Feb; 77(2):186-194. PubMed ID: 32943280
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysis.
Dawwas GK; Barnes GD; Dietrich E; Cuker A; Leonard CE; Genuardi MV; Lewis JD
Am Heart J; 2021 Dec; 242():71-81. PubMed ID: 34450051
[TBL] [Abstract][Full Text] [Related]
10. Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database).
Gandhi SK; Reiffel JA; Boiron R; Wieloch M
Am J Cardiol; 2021 Nov; 159():79-86. PubMed ID: 34656316
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety Outcomes of Direct Oral Anticoagulants and Amiodarone in Patients with Atrial Fibrillation.
Lupercio F; Romero J; Peltzer B; Maraboto C; Briceno D; Villablanca P; Ferrick K; Gross JN; Kim S; Fisher J; Di Biase L; Krumerman A
Am J Med; 2018 May; 131(5):573.e1-573.e8. PubMed ID: 29274758
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulant use and the incidence of bleeding in the very elderly with atrial fibrillation.
Khan F; Huang H; Datta YH
J Thromb Thrombolysis; 2016 Nov; 42(4):573-8. PubMed ID: 27520093
[TBL] [Abstract][Full Text] [Related]
13. Adverse outcomes associated with inappropriate direct oral anticoagulant starter pack prescription among patients with atrial fibrillation: a retrospective claims-based study.
Feng Y; Pai CW; Seiler K; Barnes GD
J Thromb Thrombolysis; 2021 May; 51(4):1144-1149. PubMed ID: 33389520
[TBL] [Abstract][Full Text] [Related]
14. Real-life behaviour of direct oral anticoagulants in a Spanish cohort with non-valvular atrial fibrillation: Refase Registry.
Navarro-Almenzar B; Cerezo-Manchado JJ; Caro-Martinez C; García-Candel F; Flores Blanco PJ; Ruiz GE; Andreu Cayuelas JM; Montoya FA; Cascales A; Lova Navarro A; García Alberola A; Andrés Pascual Figal D; Bailen Lorenzo JL; Manzano-Fernández S
Curr Med Res Opin; 2019 Dec; 35(12):2035-2041. PubMed ID: 31335222
[No Abstract] [Full Text] [Related]
15. Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients.
Hirsh Raccah B; Rottenstreich A; Zacks N; Muszkat M; Matok I; Perlman A; Kalish Y
J Thromb Thrombolysis; 2018 Nov; 46(4):521-527. PubMed ID: 30196343
[TBL] [Abstract][Full Text] [Related]
16. Association Between Use of Pharmacokinetic-Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case-Control Study.
Gronich N; Stein N; Muszkat M
Clin Pharmacol Ther; 2021 Dec; 110(6):1526-1536. PubMed ID: 34287842
[TBL] [Abstract][Full Text] [Related]
17. Renal function and risk of stroke and bleeding in patients undergoing catheter ablation for atrial fibrillation: Comparison between uninterrupted direct oral anticoagulants and warfarin administration.
Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
Heart Rhythm; 2018 Mar; 15(3):348-354. PubMed ID: 29107192
[TBL] [Abstract][Full Text] [Related]
18. Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation.
Goriacko P; Veltri KT
Eur J Haematol; 2018 May; 100(5):488-493. PubMed ID: 29444357
[TBL] [Abstract][Full Text] [Related]
19. The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation.
van den Dries CJ; van Doorn S; Souverein P; Pajouheshnia R; Moons KGM; Hoes AW; Geersing GJ; van den Ham HA
TH Open; 2020 Oct; 4(4):e417-e426. PubMed ID: 33376941
[No Abstract] [Full Text] [Related]
20. In-Hospital Bleeding Outcomes of Myocardial Infarction in the Era of Warfarin and Direct Oral Anticoagulants for Atrial Fibrillation in the United States: A Report From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry.
Feldman DN; Wang TY; Chen AY; Swaminathan RV; Kim LK; Wong SC; Minutello RM; Bergman G; Singh HS; Madias C
J Am Heart Assoc; 2019 Apr; 8(8):e011606. PubMed ID: 30955406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
